{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "A30P and A53T variants in Î±-synuclein (SNCA) are mentioned as pathogenic mutations associated with Parkinson's disease."
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Deletion of residues 56-102 (exon 4) and 130-140 (exon 6) in SNCA were tested for functional effects on PLD2 inhibition."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005307"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro enzyme inhibition assay",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "N.D.",
        "Description": "N.D."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "A30P",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "A30P was shown to have comparable PLD2 inhibition to wild-type SNCA."
        },
        {
          "Variant": "A53T",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "A53T exhibited enhanced PLD2 inhibition compared to wild-type SNCA."
        },
        {
          "Variant": "Deletion of residues 56-102 (exon 4)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Deletion of exon 4 (residues 56-102) reduced PLD2 inhibition activity."
        },
        {
          "Variant": "Deletion of residues 130-140 (exon 6)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Deletion of exon 6 (residues 130-140) significantly impaired PLD2 inhibition."
        },
        {
          "Variant": "Phosphorylation at S129",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Phosphorylation at S129 was shown to modulate PLD2 inhibition activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}